SEC Form 4 · accession 0001073396-15-000001
ICU MEDICAL INC/DE · ICUI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John J Connors
Director
Period of report
Feb 13, 2015
Accepted (ET)
Feb 13, 2015 · 8:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883984
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 13, 2015 | X | 8,500 | $35.00 | A | 10,340 | D | |
| Common Stock | Feb 13, 2015 | X | 1,500 | $29.77 | A | 11,840 | D | |
| Common StockF1 | Feb 13, 2015 | S | 9,611 | $88.2829 | D | 2,229 | D | |
| Common StockF2 | Feb 13, 2015 | S | 389 | $88.8969 | D | 1,840 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $29.77 | Feb 13, 2015 | X | 1,500 | D | Jan 30, 2012 | Jan 20, 2018 | Common Stock | 1,500 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $35.00 | Feb 13, 2015 | X | 8,500 | D | Aug 14, 2012 | Aug 14, 2017 | Common Stock | 8,500 | 0 | D |
Explanation of responses
- F1The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.83 to $88.69, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F2The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.84 to $88.99, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3Transaction is the exercise of a derivative security; see Column 2.